Discontinued — last reported Q1 '19

Business Segments · Restructuring Settlement And Impairment Provisions

Life Sciences Solutions — Restructuring Settlement And Impairment Provisions

Analysis

StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityVolatile
First reportedQ1 2016
Last reportedQ1 2019
Rolls up toImpairment and restructuring

How to read this metric

An increase suggests significant operational changes, potential integration challenges from past acquisitions, or asset underperformance, while a decrease indicates a more stable operational environment with fewer non-recurring charges.

Detailed definition

This metric represents the non-recurring expenses incurred by the Life Sciences Solutions segment related to organizatio...

Peer comparison

Peers in the life sciences and diagnostics sector frequently report similar restructuring and impairment charges during periods of M&A integration or strategic portfolio optimization.

Metric ID: tmo_segment_life_sciences_solutions_restructuring_settlement_and_impairment_provisions

Similar Metrics at Other Companies

Motorola Solutions, Inc. logo
Motorola Solutions, Inc.MSIView metric
Teradyne, Inc. logo
Teradyne, Inc.TERView metric
Warner Bros. Discovery, Inc. logo
Warner Bros. Discovery, Inc.WBDView metric
McKesson logo
McKessonMCKView metric
Pfizer logo
PfizerPFEView metric
Teradyne, Inc. logo
Teradyne, Inc.TERView metric

Frequently Asked Questions

What does life sciences solutions — restructuring settlement and impairment provisions mean?
The total costs associated with reorganizing business operations, settling legal disputes, and writing down the value of assets within the Life Sciences Solutions segment.